Chronic Kidney Disease (CKD) affects approximately 15% of U.S. adults and as many as 9 in 10 with CKD are unaware they have it. The kidneys filter waste and excess fluid from the blood and ...

In a meeting of its General House today, the Chief Khalsa Diwan (CKD) approved a budget of Rs 181.05 crore for the financial ...

Chronic kidney disease (CKD), affecting 35.5 million Americans, often goes undiagnosed. High blood pressure and diabetes are key risk factors. Early intervention can prevent progression, yet many ...

Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment. SGLT2i are recommended for CKD patients, regardless of diabetes status, for kidney and ...

Medscape Medical News, March 14, 2025 Tolvaptan Slows Progression in Genetic Kidney Disease A real-world long-term analysis reveals the benefits of tolvaptan in slowing kidney function decline in ...

In 2022-23, the survey said that 6,521 CKD cases were reported. Despite the rising graph seen in the survey's figures, experts feel that the real burden of CKD could be higher. Dr Shah said that ...

Updates on chronic kidney disease (CKD) diagnosis, use of sodium–glucose cotransporter-2 (SGLT-2) inhibitors as first-line therapy, and personalized treatment approaches for kidney and ...

About one in seven people in the United States suffers from chronic kidney disease (CKD), with diabetic kidney disease (DKD) being the main cause.With ...

The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to discuss integrated evidence plans, data sharing optimization, infrastruc ...

The CKD indication is expected to be a meaningful growth driver for FUROSCIX. The company has already received early prescriptions from nephrologists and is preparing for a full-scale launch in ...